The Complementary Healthcare Council of Australia (CHC) contests the recent US research reported in the Journal of the National Cancer Institute linking Omega-3 and prostate cancer as inconclusive and contradictory of a large pool of pre-existing, robust evidence that demonstrates the positive health benefits of fish oil. This case-cohort study examines associations between plasma phospholipid fatty acids and prostate cancer risk among participants in the Selenium and Vitamin E Cancer Prevention Trial.

Read the Media Release here.